U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07798479) titled 'Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter Study' on Aug. 24.
Brief Summary: This study investigates whether a patient's age affects the outcomes of Bacillus Calmette-Guerin (BCG) treatment for high-grade bladder cancer.
Bladder cancer is a common cancer that can sometimes grow into the deeper layers of the bladder wall. In this study, we focus on patients with primary pT1 high-grade bladder cancer, a form of bladder cancer with a higher risk of coming back or progressing. Standard treatment includes removal of the tumor through the urethra (transurethral resection), a second procedure to check that no tumor...